Federal · Title 21 — Food and Drugs
21 U.S.C. § 360ee: FDA rare neurodegenerative disease grant program
Read the full statutory text
to characterize such neurodegenerative diseases and their natural history; to identify molecular targets for such neurodegenerative diseases; and the use of master protocols and adaptive and add-on clinical trial designs; and efforts to establish new or leverage existing clinical trial networks.
Verify at the official source: Federal legislative text
Facing this? Know exactly what happens next.
MOFRD turns this code section into your situation: the deadlines that apply to you, the forms your county uses, and the resolution paths people in your position actually take. Free for 3 days — no card required.
This page is legal information, not legal advice. Code text is sourced from official publications and may lag amendments — always confirm at the official source linked above. Plain-English summaries and relationship data are AI-derived and reviewed on an ongoing basis; verify with a licensed attorney before acting.